Literature DB >> 17337340

Effects of acute antipsychotic treatment on brain activation in first episode psychosis: an fMRI study.

P Fusar-Poli1, M R Broome, P Matthiasson, S C R Williams, M Brammer, P K McGuire.   

Abstract

This study aimed to assess the neurophysiological effects of acute atypical antipsychotic treatment on cognitive functioning in subjects presenting with a first episode of psychosis. We used functional MRI to examine the modulatory effects of acute psychopharmacological intervention on brain activation during four different cognitive tasks: overt verbal fluency, random movement generation, n-back and a spatial object memory task. Treatment with atypical antipsychotics was associated with alterations in regional activation during each task and also when task demands were manipulated within paradigms. The initial treatment of psychosis with atypical antipsychotics thus appears to be associated with modifications of the neurofunctional correlates of executive and mnemonic functions. These effects need to be considered when interpreting group differences in activation between medicated patients and controls.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337340     DOI: 10.1016/j.euroneuro.2007.01.003

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  13 in total

Review 1.  Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis.

Authors:  Paolo Fusar-Poli
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

2.  Changes in prefrontal and amygdala activity during olanzapine treatment in schizophrenia.

Authors:  Giuseppe Blasi; Teresa Popolizio; Paolo Taurisano; Grazia Caforio; Raffaella Romano; Annabella Di Giorgio; Fabio Sambataro; Valeria Rubino; Valeria Latorre; Luciana Lo Bianco; Leonardo Fazio; Marcello Nardini; Daniel R Weinberger; Alessandro Bertolino
Journal:  Psychiatry Res       Date:  2009-05-09       Impact factor: 3.222

Review 3.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

4.  Prefrontal function at presentation directly related to clinical outcome in people at ultrahigh risk of psychosis.

Authors:  P Fusar-Poli; M R Broome; P Matthiasson; J B Woolley; A Mechelli; L C Johns; P Tabraham; E Bramon; L Valmaggia; S C Williams; P McGuire
Journal:  Schizophr Bull       Date:  2009-08-07       Impact factor: 9.306

5.  Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies.

Authors:  Paolo Fusar-Poli; Joaquim Radua; Philip McGuire; Stefan Borgwardt
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

6.  Neural correlates of aberrant emotional salience predict psychotic symptoms and global functioning in high-risk and first-episode psychosis.

Authors:  Gemma Modinos; Huai-Hsuan Tseng; Irina Falkenberg; Carly Samson; Philip McGuire; Paul Allen
Journal:  Soc Cogn Affect Neurosci       Date:  2015-03-25       Impact factor: 3.436

Review 7.  A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.

Authors:  Sarel J Brand; Marisa Moller; Brian H Harvey
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 8.  Neurobiological markers of illness onset in psychosis and schizophrenia: The search for a moving target.

Authors:  Christos Pantelis; Murat Yücel; Emre Bora; Alex Fornito; Renée Testa; Warrick J Brewer; Dennis Velakoulis; Stephen J Wood
Journal:  Neuropsychol Rev       Date:  2009-09       Impact factor: 7.444

Review 9.  Repetitive Transcranial Magnetic Stimulation as a Therapeutic and Probe in Schizophrenia: Examining the Role of Neuroimaging and Future Directions.

Authors:  Stephen J Brandt; Halimah Y Oral; Carla Arellano-Bravo; Martin H Plawecki; Tom A Hummer; Michael M Francis
Journal:  Neurotherapeutics       Date:  2021-04-12       Impact factor: 7.620

Review 10.  Do subjects at clinical high risk for psychosis differ from those with a genetic high risk?--A systematic review of structural and functional brain abnormalities.

Authors:  R Smieskova; J Marmy; A Schmidt; K Bendfeldt; A Riecher-Rӧssler; M Walter; U E Lang; S Borgwardt
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.